Though the serum Cav-1 levels of patients with acute ischemic stroke were tremendously higher than the control group and the MMD group, patients with recurrent episode of ischemia or infarction (the Matsushima scale I–V) were comparable with that in patients in the Matsushima scale VI. This evidence concerns the gene CAV1 and infarction.